Prof. Dr. Fatma Tümay Sözen

Endocrinology and Metabolic Diseases

GENERAL INFORMATION
Company
HC International Clinic Surgical Medicine Center

Medical Units
Endocrinology and Metabolic Diseases

WORKING INSTITUTIONS

HC INTERNATIONAL CLINIC SURGICAL MEDICINE CENTER
2018 – ,Endocrinology and Metabolic Diseases
SCHOOL OF MEDICINE, NEAR EAST UNIVERSITY, NICOSIA, TRNC
2010 – 2016, Head, Department of Internal Medicine
SCHOOL OF MEDICINE, NEAR EAST UNIVERSITY, NICOSIA, TRNC
2010 – 2016, Head, Internal Medicine Disciplines
TURKISH SOCIETY OF ENDOCRIONOLOGY AND METABOLISM
1994 – 2014, Head of Osteoporosis and Other Bone Diseases Study Group
SCHOOL OF MEDICINE, HACETTEPE UNIVERSITY
2000 – 2009, Head, General Internal Medicine Unit
SCHOOL OF MEDICINE, HACETTEPE UNIVERSITY
1988 – , Professor, Internal Medicine
SCHOOL OF MEDICINE, HACETTEPE UNIVERSITY
1979 – , Associate Professor of Internal Medicine
WAYNE STATE UNIVERSITY AB
1973 – 1975, Endocrinology Fellow

SCHOOL OF MEDICINE, HACETTEPE UNIVERSITY
1972 – 1973, Endocrinology Fellow
UNIVERSITY OF MICHIGAN, U.S.A., AFFILIATED ST JOSEPH MERCY HOSPITAL
– UNIVERSITY OF MICHIGAN, U.S.A., AFFILIATED ST JOSEPH MERCY HOSPITAL
MICHIGAN STATE UNIVERSITY, U.S.A.
1969 – 1970, Resident

CONTACT INFORMATION
E-Mail Address
tsozen@hcintclinic.com
Phone Number
(312) 408-2121
EDUCATION

SCHOOL OF MEDICINE, HACETTEPE UNIVERSITY
1965 – 1968, Internal Medicine Residency
SCHOOL OF MEDICINE, ANKARA UNIVERSITY
1959 – 1965, Medical Education

AREAS OF INTEREST

-Osteoporosis
-Thyroid
-Diabetes Mellitus

1- Overbeck HW, Sözen T, Derifield RS. Limb vascular responses to K in Normotensive
and Essential Hypertensive men. Clin Res 29:332,1971.
2- Overbeck HW, Derifield RS, Pamnani MB, Sözen T. Attenuated vasodilator responses
to K in essential Hypertensive men J Clin Invest 53: ,1974.
3- Lucas CP, Holzwarth G, Ocobock R, Sözen T, Stern M, Wood P, Haskell W, Farquar J.
Disturbed relatıon of plasma renin to blood pressure in hypertension. Lancet 2: 1337, 1974.
4-Sözen T, Bagchi N, Lucas CP. Aldosteronism . Vascular Surgery 9 : 228 1975.
5- Lucas CP, Sözen T, Ocobock R , Holzwarth G, Sözen T, Stern M, Wood P, Haskell W,
Farquar J. Renin activity , renin concentratıon and renin reactivity in essential Hypertension.
J. Vascular Diseases 26: (ı) 31, 1975.
6- Oto AM, Sözen T, Boyacıoğlu S. Pulse therapy in Systemic Lupus Erythematosus..
Annals of Rheumatic Disease 40: 630,1981 ( Letter )
7- Oktay A , Oto AM, Arıoğul S, Sözen T, Sandıkçı S., Biberoğlu K. Familial Mediterranean
Fever and amyloidosis . Asian Med. J. 26: 562,1983.
8- Oto AM, Sözen T. Methyl prednisolon pulse therapy and peritonitis. Ann Int Med
99:282,1983( Letter).
9- Sözen T, Oktay A , Oto AM, Arıoğul S, Sandıkçı S., Biberoğlu K.Amyloidosis: Clinical
Analysis of 190 cases. Asian Med. J 26: 365, 1983.
10-Sözen T.Dündar S, Oto A, Oktay A, Arıoğul S. “Behçet’s Disease associated with
amyloidosis” Isr J Med Sci 20, 1071-72,1984
11- Oto AM, Sözen T, Özışık Y. Pulse methylprednisolon therapy in ididopathic
thrombocytopenic purpura. Acta Haematologica 70:345,1983
12- Sözen T. Ateş B: Behçet’s syndrome and acyclovir. Ann Int Med 101,406,1984( letter)
13- Sözen T, Dündar S, Oto MA Oktay A, Arıoğul : Behçet’s disease associated with
amyloidosis. Nephron 39: 402, 1985. ( letter)
14-, Oto MA, Oktay A, Dündar S, Arıoğul S, Sözen T, Sandıkçı S, Biberoğlu K, Behçet’s
Disease. Clinical analysis of 85 cases. Asian Medical Journal 28: 580; 1985.
15- Sözen T, Gedik O, Bayraktar M: Diabetic ketoalkalosis in Cushing ‘s syndrom.e Israel
Journal Med Sciences.23: 907; 1987.
16- Sayınalp S, Sözen T, Özdoğan M: Cold pressor test in diabetic autonomic neuropathy.
Diabetes Research & Clinical Practice 26:21-28,1994
17-Oz SG, Guven GS, Kilicarslan A, Calik N, Beyazit Y, Sozen T. “Evaluation of bone
metabolism and bone mass in patients with type-2 diabetes mellitus”, Natl Med Assoc, 98:
1598-1604 (2006).
18 -Güven GS, Kılıçarslan A, Oz SG, Haznedaroğlu IC, Kirazlı S,Aslan D, Sozen T:
Decrements in the thrombin activatable fibrinolysis inhibitor (TAFI) levels in associationwith
orlistat treatment in obesity.Clin Appl Thromb Hemost. 2006 Jul;12(3):364-8.
19 -Kiliçarslan A, İşildak M, Guven GS, Tarıover MD, Duman AE, Saracbası O, Sozen
T: Demographic, socioeconomic and educational aspects of obesity in an adult population. J
Natl Med Assoc. 2006 Aug;98(8):1313-7.
20 – Guven GS, Atalar E, Yavuz B, Beyazit Y, Kekili M, Kiliçarslan A, Sahiner L, Oz SG,
Aksöyek S, Haznedaroglu IC, Sozen T: Simvastatin treatment improves endothelial function
and increases fibrinolysis in patients with hypercholestrolemia.J Natl Med Assoc. 2006
Apr;98(4):627-30.
21 -Guven GS, Çakır B, Oz SG, Tanrıover MD, Turkmen E, Sozen T.:Could remembering
the prozone phenomenon shorten our diagnostic journey in brucellosis?A case Brucella
spondylodiscitis. Rheumatol Int. 2006 Aug;26(10):933-5. E pub 2006 Feb 17.
22-Oz SG, Kiliçarslan A, Güven GS, Tanrıover MD, Aykaç Y, Sozen T : Beneficial effects
of periodontal treatment on metabolic control of hypercholesterolemia. South Med J. 2007
Jul;100(7):686-91.
23 – Kilicarslan A, Isildak M, Guven GS,. Oz GS, Hasbay A, Karabulut E, Sozen T:
The Influence of Ballet Training on Bone Mass in Turkish Ballet Dancer. The Endocrinologist
2007;17:march , april
24-Oz SG, Fentoglu O, Kilicarslan A, Guven GS, Tanrıover MD, Aykac Y, Sozen T.
“Benefical Effects of Periodontal Treatment on Metabolic Control of Hypercholesterolemia”,
South Med J, 100, 686-691, (2007).
25 – Kilicarslan A, B Yavuz, GS Güven, E Atalar, L Sahiner, Y Beyazıt M Kekili, N Özer, G
Oz, IC Haznedaroğlu, T Sozen . “Fenofibrate improves endothelial function and decreases
thrombin –activatable fibrinolysis inhibitor concentration in metabolic syndrome”.Blood
Coagul Fibrinolysis 19: 5,(2008).
26 -Tanriover MD, Oz SG, Sozen T, Kilicarslan A, Guven GS, Pregnancy- and lactation
associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new
alternative for the treatment?, Spine J. 9, e20-4 (2009).
27- Tanriover MD, Oz SG, Sozen T, Kilicarslan A, Guven GS. “Pregnancy- and lactation-
associated osteoporosis with severe vertebral deformities: Can strontium ranelate be a new
alternative for the treatment ?”, Spine J, 9(4):e20-4, (2009).
28- Tanriover MD, Oz SG, Tanriover A, Kilicarslan A, Turkmen E, Guven GS, Saracbasi O,
Tokgozoglu M, Sozen T, Hip fractures in a developing country: osteoporosis frequency,
predisposing factors and treatment costs, published online Arch Gerontol Geriatr,
50(3):e13-8, (2010).
29- Fentoplu Ö, Sözen T ,Öz G, Köroğlu BK, Sönmez Y, Tonguç MÖ, Güngan CA, Aykaç
Y, Kırmızıoğlu Y. Short-Term Effects Of Periodontal Therapy As An Adjunct To Antı-Lıpemıc
Treatment. Oral Diseases. 16(7) 648-54 2010
30 . Durusu Tanriover M, Bora Tatar G, Uluturk TD, Dayangac Erden D, Tanriover A,
Kilicarslan A, Oz SG, Erdem Yurter H, Sozen T, Sain Guven G. “Evaluation of the effects of
vitamin D receptor and estrogen receptor 1 gene polymorphisms on bone mineral density in
postmenopausal women”, Clin Rheumatol. 29(11):1285-93, (2010). Epub2010 Aug 10
31-Öz SG,Tozlu M,Yaçın SS,Sözen T,Güven GS. Mercury vapor inhalation and poisining of
a family . Inhalation Toxicology 24(10): 652-8, 2012
32- Tanriover MD, Oz SG, Sozen T.Ten-year follow-up in pregnancy and lactation
associated osteoporosis: sequential therapy with strontium ranelate and ibandronate, Letters
to the Editor The Spine Journal 15 (2015) 1164–1166